LIFESTANCE HEALTH GROUP INC (LFST) Stock Fundamental Analysis
USA - NASDAQ:LFST - US53228F1012 - Common Stock
6.29 USD
+0.04 (+0.64%)
6.35 USD
+0.06 (+0.95%)
Taking everything into account, LFST scores 3 out of 10 in our fundamental rating. LFST was compared to 100 industry peers in the Health Care Providers & Services industry. While LFST seems to be doing ok healthwise, there are quite some concerns on its profitability. LFST is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year LFST has reported negative net income.
LFST had a positive operating cash flow in the past year.
LFST had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LFST reported negative operating cash flow in multiple years.
1.2 Ratios
LFST has a Return On Assets (-0.75%) which is comparable to the rest of the industry.
LFST has a Return On Equity of -1.10%. This is comparable to the rest of the industry: LFST outperforms 53.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | -1.1% | ||
| ROIC | N/A |
ROA(3y)-7.15%
ROA(5y)-11.83%
ROE(3y)-10.4%
ROE(5y)-16.72%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
LFST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFST has more shares outstanding
The number of shares outstanding for LFST has been increased compared to 5 years ago.
LFST has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.32 indicates that LFST is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.32, LFST perfoms like the industry average, outperforming 53.00% of the companies in the same industry.
The Debt to FCF ratio of LFST is 2.36, which is a good value as it means it would take LFST, 2.36 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LFST (2.36) is better than 81.00% of its industry peers.
LFST has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.19, LFST is doing good in the industry, outperforming 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 2.32 |
ROIC/WACCN/A
WACC9.26%
2.3 Liquidity
A Current Ratio of 1.48 indicates that LFST should not have too much problems paying its short term obligations.
With a Current ratio value of 1.48, LFST perfoms like the industry average, outperforming 53.00% of the companies in the same industry.
LFST has a Quick Ratio of 1.48. This is a normal value and indicates that LFST is financially healthy and should not expect problems in meeting its short term obligations.
LFST has a Quick ratio of 1.48. This is comparable to the rest of the industry: LFST outperforms 59.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.48 |
3. Growth
3.1 Past
LFST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.46%, which is quite impressive.
Looking at the last year, LFST shows a quite strong growth in Revenue. The Revenue has grown by 18.50% in the last year.
LFST shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.55% yearly.
EPS 1Y (TTM)88.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)18.5%
Revenue growth 3Y23.29%
Revenue growth 5Y42.55%
Sales Q2Q%16.34%
3.2 Future
Based on estimates for the next years, LFST will show a very strong growth in Earnings Per Share. The EPS will grow by 46.80% on average per year.
Based on estimates for the next years, LFST will show a quite strong growth in Revenue. The Revenue will grow by 12.39% on average per year.
EPS Next Y80.88%
EPS Next 2Y50.17%
EPS Next 3Y46.8%
EPS Next 5YN/A
Revenue Next Year14.25%
Revenue Next 2Y14.19%
Revenue Next 3Y14.5%
Revenue Next 5Y12.39%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
LFST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 154.17, the valuation of LFST can be described as expensive.
Based on the Price/Forward Earnings ratio, LFST is valued a bit more expensive than 63.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LFST to the average of the S&P500 Index (32.73), we can say LFST is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 154.17 |
4.2 Price Multiples
LFST's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LFST indicates a somewhat cheap valuation: LFST is cheaper than 63.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.37 | ||
| EV/EBITDA | 44.22 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LFST does not grow enough to justify the current Price/Earnings ratio.
LFST's earnings are expected to grow with 46.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.17%
EPS Next 3Y46.8%
5. Dividend
5.1 Amount
No dividends for LFST!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.29
+0.04 (+0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners38%
Inst Owner Change-1.03%
Ins Owners3%
Ins Owner Change-8.79%
Market Cap2.45B
Revenue(TTM)1.25B
Net Income(TTM)-16.15M
Analysts84.29
Price Target8.5 (35.14%)
Short Float %4.23%
Short Ratio3.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.66%
Min EPS beat(2)67.32%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)70.6%
Min EPS beat(4)43.98%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)24.17%
EPS beat(12)9
Avg EPS beat(12)15.58%
EPS beat(16)9
Avg EPS beat(16)3.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.94%
Min Revenue beat(2)-1.94%
Max Revenue beat(2)-1.93%
Revenue beat(4)2
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)1.72%
Revenue beat(8)4
Avg Revenue beat(8)0.36%
Revenue beat(12)6
Avg Revenue beat(12)0.34%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)-1.13%
PT rev (3m)0.25%
EPS NQ rev (1m)-50.06%
EPS NQ rev (3m)-25%
EPS NY rev (1m)-23.51%
EPS NY rev (3m)38.46%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-0.79%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 154.17 | ||
| P/S | 1.86 | ||
| P/FCF | 20.37 | ||
| P/OCF | 16.69 | ||
| P/B | 1.66 | ||
| P/tB | N/A | ||
| EV/EBITDA | 44.22 |
EPS(TTM)-0.03
EYN/A
EPS(NY)0.04
Fwd EY0.65%
FCF(TTM)0.31
FCFY4.91%
OCF(TTM)0.38
OCFY5.99%
SpS3.38
BVpS3.79
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | -1.1% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 9.12% |
ROA(3y)-7.15%
ROA(5y)-11.83%
ROE(3y)-10.4%
ROE(5y)-16.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 4.75 | ||
| Cap/Depr | 45.9% | ||
| Cap/Sales | 2.01% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 255.02% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.48 | ||
| Altman-Z | 2.32 |
F-Score7
WACC9.26%
ROIC/WACCN/A
Cap/Depr(3y)65.1%
Cap/Depr(5y)98.49%
Cap/Sales(3y)4.93%
Cap/Sales(5y)7.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y80.88%
EPS Next 2Y50.17%
EPS Next 3Y46.8%
EPS Next 5YN/A
Revenue 1Y (TTM)18.5%
Revenue growth 3Y23.29%
Revenue growth 5Y42.55%
Sales Q2Q%16.34%
Revenue Next Year14.25%
Revenue Next 2Y14.19%
Revenue Next 3Y14.5%
Revenue Next 5Y12.39%
EBIT growth 1Y99.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year441.48%
EBIT Next 3Y95.15%
EBIT Next 5YN/A
FCF growth 1Y1147.77%
FCF growth 3YN/A
FCF growth 5Y99.09%
OCF growth 1Y339.74%
OCF growth 3Y124.97%
OCF growth 5Y44.46%
LIFESTANCE HEALTH GROUP INC / LFST FAQ
What is the fundamental rating for LFST stock?
ChartMill assigns a fundamental rating of 3 / 10 to LFST.
What is the valuation status of LIFESTANCE HEALTH GROUP INC (LFST) stock?
ChartMill assigns a valuation rating of 2 / 10 to LIFESTANCE HEALTH GROUP INC (LFST). This can be considered as Overvalued.
What is the profitability of LFST stock?
LIFESTANCE HEALTH GROUP INC (LFST) has a profitability rating of 1 / 10.